Clarissa Desjardins's most recent trade in Insmed Inc was a trade of 1,895 Common Stock done at an average price of $66.9 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Clarissa Desjardins | Director | Purchase of securities on an exchange or from another person at price $ 66.87 per share. | 20 May 2025 | 1,895 | 1,895 (0%) | 0% | 66.9 | 126,719 | Common Stock |
| Insmed Inc | Clarissa Desjardins | Director | Purchase of securities on an exchange or from another person at price $ 66.35 per share. | 20 May 2025 | 1,130 | 3,025 (0%) | 0% | 66.4 | 74,976 | Common Stock |
| Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,058 | 67,007 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 61,949 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 48,787 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 35,595 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Clarissa Desjardins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 20,950 (0%) | 0% | - | Common Stock |